- Home
- MAXN vs CUE Comparison
MAXN vs CUE Comparison
Compare MAXN & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAXN
- CUE
- Stock Information
- Founded
- MAXN 2019
- CUE 2014
- Country
- MAXN Singapore
- CUE United States
- Employees
- MAXN N/A
- CUE N/A
- Industry
- MAXN Semiconductors
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- MAXN Technology
- CUE Health Care
- Exchange
- MAXN Nasdaq
- CUE Nasdaq
- Market Cap
- MAXN 62.5M
- CUE 64.4M
- IPO Year
- MAXN N/A
- CUE 2018
- Fundamental
- Price
- MAXN $9.98
- CUE $1.25
- Analyst Decision
- MAXN Sell
- CUE Strong Buy
- Analyst Count
- MAXN 7
- CUE 5
- Target Price
- MAXN $246.50
- CUE $5.00
- AVG Volume (30 Days)
- MAXN 2.7M
- CUE 971.4K
- Earning Date
- MAXN 11-22-2024
- CUE 11-14-2024
- Dividend Yield
- MAXN N/A
- CUE N/A
- EPS Growth
- MAXN N/A
- CUE N/A
- EPS
- MAXN N/A
- CUE N/A
- Revenue
- MAXN $828,080,000.00
- CUE $9,532,000.00
- Revenue This Year
- MAXN N/A
- CUE $104.81
- Revenue Next Year
- MAXN $29.41
- CUE N/A
- P/E Ratio
- MAXN N/A
- CUE N/A
- Revenue Growth
- MAXN N/A
- CUE 149.53
- 52 Week Low
- MAXN $4.98
- CUE $0.45
- 52 Week High
- MAXN $780.00
- CUE $3.25
- Technical
- Relative Strength Index (RSI)
- MAXN 52.78
- CUE 43.10
- Support Level
- MAXN $8.06
- CUE $1.32
- Resistance Level
- MAXN $14.49
- CUE $1.99
- Average True Range (ATR)
- MAXN 2.19
- CUE 0.29
- MACD
- MAXN 0.39
- CUE -0.06
- Stochastic Oscillator
- MAXN 46.37
- CUE 0.67
About MAXN Maxeon Solar Technologies Ltd.
Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.